MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Recall of Thousands of MRI Scanners Issued by US FDA

By MedImaging International staff writers
Posted on 23 Feb 2015
Print article
The United States (US) Food and Drug Administration (FDA) has issued a Class 1 Recall notice for a large number of GE Healthcare (Chalfont St. Giles, Buckinghamshire, UK) Magnetic Resonance Imaging (MRI) systems. All MRI systems using superconducting magnets, manufactured from 1985 to the present are affected. The notice was dated February 18th, 2015.

Already on January 6, 2015, GE Healthcare had sent an "Urgent Medical Device Correction" letter to hospital administrators/risk managers, radiology department managers, and radiologists, in the US and around the world. The letter described the safety issue, safety instructions, affected product details, product correction and contact information. The letter was necessary when GE Healthcare discovered that the Magnet Rundown Units (MRU) on its imaging devices may not be properly connected.

To correct the issue, GE Healthcare has instructed customers to perform preventative measures to confirm that the MRU is connected to the magnet. The measures consist of a four-step test on the MRU. The steps are explained on the GE Healthcare and FDA websites.

According the FDA recall notice, “In emergency situations, a disconnected MRU could delay removal of a ferrous object from the magnet, potentially resulting in life-threatening injuries.”

Related Links:

GE Healthcare
US Food and Drug Administration (FDA)


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Mobile Digital C-arm X-Ray System
HHMC-200D
New
Ultrasound System
P20 Elite
PACS Workstation
CHILI Web Viewer

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more